1 Reason to Buy NuScale Power and Hold Until 2033

NuScale Power remains the only U.S. nuclear company with an NRC-approved SMR design, giving it a regulatory first-mover advantage. The article highlights a 463 MWe Romania project and a first commercial reactor expected in 2033, while noting ENTRA1 Energy could benefit from a potential $25 billion Japanese investment tied to nuclear power for AI demand. Shares trade about 75% below all-time highs, framing the setup as speculative but potentially attractive for patient investors.

Analysis

SMR is less a near-term earnings story than a regulatory-optionality trade, and that creates a very asymmetric setup versus the rest of the SMR basket. NRC approval is the key bottleneck in a market where capital is starting to price “licensability” as the scarce asset; that should keep a premium on SMR while compressing enthusiasm for pre-approved peers until they show a credible path to grid connection. The second-order effect is that any real deployment milestone can trigger a re-rating not just in SMR, but across the entire domestic nuclear supply chain as investors re-underwrite execution risk rather than design risk.

The market is likely underestimating the duration mismatch here. A 2033 first-commercial target means the equity is still trading on a decade-long delivery bridge, so the stock will remain highly sensitive to financing terms, partner credibility, and policy support rather than construction economics. In that setup, upside tends to come in bursts around de-risking events, while downside is slower but more grinding if schedule slips force repeated dilution or partner dependence becomes more visible.

The contrarian view is that the current discount may already reflect the obvious risks, while the real upside comes from the scarce strategic asset: regulatory acceptance in a sector where time-to-license is often more valuable than technology novelty. If broader power demand from AI keeps tightening the narrative, investors may pay for a “shovel-ready” nuclear platform years before the first reactor is built. That said, the best risk/reward is probably not outright long-only exposure to the whole theme, but owning the approved leader against the unproven peers and using catalysts to trade dispersion.

Key Decisions for Investors

• Long SMR / short OKLO or NNE as a 6-12 month relative-value pair: the approved design should retain a licensing premium until competitors show comparable regulatory progress; target 15-25% relative outperformance, with the main risk being a broad sentiment squeeze in the nuclear theme.
• Use pullbacks in SMR to build a starter long only on confirmation of financing or project-step milestones, not on headline optimism; this is a 12-24 month catalyst path, and entry should be sized for high volatility and potential dilution.
• Avoid chasing OKLO and NNE on narrative alone until they clear the same regulatory hurdle; the risk/reward is skewed negative if capital rotates back toward “approved first, build later” names over the next 3-9 months.
• Buy upside calls on SMR into catalyst windows rather than stock if positioning is already crowded; options give exposure to a sharp rerating on partner or project news while capping downside if timelines slip.
• Monitor policy/AI-power headlines as a sector trigger: if data-center electricity demand accelerates, rotate into SMR and add to the long/short pair, because the market will likely pay up for pre-commercial scarcity before it pays for operating cash flow.